Lung Cancer - Page 19

November 18, 2015

Glowing terms often used for new cancer drugs in health news

Health news stories often use overly optimistic terms to describe new cancer drugs, according to a new study.

November 10, 2015

Silicone breast implants still lack proof of safety

Good evidence on the safety of silicone gel breast implants is still lacking almost 10 years after they were reintroduced to the U.S. market, researchers report in the Annals of Internal Medicine.

November 6, 2015

Superbugs mean more infections and deaths after surgery, chemotherapy

The declining effectiveness of antibiotics may make tens of thousands more U.S. patients vulnerable to potentially fatal infections after surgery or chemotherapy, researchers estimate.

October 28, 2015

AstraZeneca boosted by start of new cancer drug trial

Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.

October 28, 2015

In old age, current and former smokers face early lung disease

There may be 35 million older Americans with undiagnosed lung disease due to cigarette smoking, a new study suggests.

October 28, 2015

European code against cancer calls for smoke-free, active lives

Cancer experts issued a 12-point code on Tuesday aimed at preventing up to half of all new cases of the disease in Europe by guiding people towards smoke-free, active lives free from cancer-causing infections and substances.

October 28, 2015

The US is about to get Cuba's lung cancer vaccine

Closer American ties with one of the world's major cigar exporters could actually be good news in the fight against lung cancer.

October 28, 2015

Lung cancer screening could cost Medicare billions, study shows

Every person covered by Medicare would shell out an additional $3 a month if the government agreed to pay to screen certain current and former smokers for lung cancer, a new study estimates.

October 28, 2015

GlaxoSmithKline lung drug fails to extend life in huge study

GlaxoSmithKline's inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of 16,500 people, torpedoing hopes of a sales boost for the drug.

October 28, 2015

Cancer remains leading cause of death among US Hispanics

Cancer remains the leading cause of death among Hispanics in the U.S., driven in large part by lung malignancies in men and breast tumors in women, a new report finds.